University in Bochum: Start Immunotherapy for Anti-IgLON5 Disease as Early as Possible
August 11, 2025
August 11, 2025
BOCHUM, Germany, Aug. 11 (TNSjou) -- The University in Bochum issued the following news release:
* * *
Start Immunotherapy for Anti-IgLON5 Disease as Early as Possible
Researchers ask physicians to consider anti-IgLON5 disease if certain symptoms are present, as the only promising approach is early treatment.
It often starts with restless sleep. Mobility, swallowing, and speaking disorders are also typical. Yet a range of other symptoms make it . . .
* * *
Start Immunotherapy for Anti-IgLON5 Disease as Early as Possible
Researchers ask physicians to consider anti-IgLON5 disease if certain symptoms are present, as the only promising approach is early treatment.
It often starts with restless sleep. Mobility, swallowing, and speaking disorders are also typical. Yet a range of other symptoms make it . . .